Telormedix is a biopharmaceutical company developing therapeutics based on targeted immunity for cancer and autoimmune diseases.
Telormedix is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 30, 2008 | Series A | $19M | 1 | — | — | Detail |